Cargando…

Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS

BACKGROUND: Risk models (RM) need external validation to assess their value beyond the setting in which they were developed. We validated a RM combining mpMRI and clinical parameters for the probability of harboring significant prostate cancer (sPC, Gleason Score ≥ 3+4) for biopsy-naïve men. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radtke, Jan Philipp, Giganti, Francesco, Wiesenfarth, Manuel, Stabile, Armando, Marenco, Jose, Orczyk, Clement, Kasivisvanathan, Veeru, Nyarangi-Dix, Joanne Nyaboe, Schütz, Viktoria, Dieffenbacher, Svenja, Görtz, Magdalena, Stenzinger, Albrecht, Roth, Wilfried, Freeman, Alex, Punwani, Shonit, Bonekamp, David, Schlemmer, Heinz-Peter, Hohenfellner, Markus, Emberton, Mark, Moore, Caroline M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710031/ https://www.ncbi.nlm.nih.gov/pubmed/31450235 http://dx.doi.org/10.1371/journal.pone.0221350

Ejemplares similares

Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
por: Görtz, Magdalena, et al.
Publicado: (2022)

Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer
por: Nyarangi-Dix, Joanne Nyaboe, et al.
Publicado: (2019)

Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score
por: Giganti, Francesco, et al.
Publicado: (2022)

Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists
por: Giganti, Francesco, et al.
Publicado: (2021)

Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021)

Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment
por: Schelb, Patrick, et al.
Publicado: (2020)

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol
por: Kasivisvanathan, Veeru, et al.
Publicado: (2017)

Detection Rate of Prostate Cancer in Repeat Biopsy after an Initial Negative Magnetic Resonance Imaging/Ultrasound-Guided Biopsy
por: Görtz, Magdalena, et al.
Publicado: (2023)

Evolution of Salvage Radical Prostatectomy from Open to Robotic and Further to Retzius Sparing Surgery
por: Schuetz, Viktoria, et al.
Publicado: (2021)

Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
por: Giganti, Francesco, et al.
Publicado: (2022)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program
por: Giganti, Francesco, et al.
Publicado: (2021)

Single-Center Evaluation of Treatment Success Using Two Different Protocols for MRI–Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer
por: Hatiboglu, Gencay, et al.
Publicado: (2021)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020)

Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study
por: Brembilla, Giorgio, et al.
Publicado: (2022)

Intravenous pyogenic granuloma of the renal vein: A rare morphological differential diagnosis to renal cell carcinoma
por: Philipp, Reimold, et al.
Publicado: (2019)

Hypospadias
por: Djakovic, N., et al.
Publicado: (2008)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
por: Asif, Aqua, et al.
Publicado: (2023)

Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer
por: Kovacs, Balint, et al.
Publicado: (2023)

Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2020)

Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
por: Giganti, Francesco, et al.
Publicado: (2019)

Histological outcomes after focal high-intensity focused ultrasound and cryotherapy
por: Shah, Taimur T., et al.
Publicado: (2015)

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
por: Campistol, Miriam, et al.
Publicado: (2022)

Correlation between genomic index lesions and mpMRI and (68)Ga-PSMA-PET/CT imaging features in primary prostate cancer
por: Kesch, Claudia, et al.
Publicado: (2018)

Significance of the Intraoperative Methylene Blue Test for Postoperative Evaluation of the Vesicourethral Anastomosis
por: Nyarangi-Dix, J. N., et al.
Publicado: (2012)

Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Tosev, Georgi, et al.
Publicado: (2021)

Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Tosev, Georgi, et al.
Publicado: (2021)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
por: Roobol, Monique J., et al.
Publicado: (2011)

Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer
por: Hatiboglu, G., et al.
Publicado: (2017)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL
por: Gomez Gomez, Enrique, et al.
Publicado: (2019)

The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
por: Santaolalla, Aida, et al.
Publicado: (2021)

Correction: Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL
Publicado: (2020)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol
por: Norris, Joseph M., et al.
Publicado: (2020)

Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma
por: Schneider, Felix, et al.
Publicado: (2023)

Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform †
por: Beyer, Katharina, et al.
Publicado: (2022)

Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK
por: Bass, Edward James, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s52hv8knvlnn90e0b8cnpus8cp